ANIP - ANI Pharmaceuticals Inc Options

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: AMRX BHC PRGO ALKS INDV LNTH TEVA VTRS KNSA TLX

| Held by: IJR VTI IWM AVUV VXF SPSM IJT IWO PJP XSMO

Scroll to Statements

Index	RUT	P/E	21.44	EPS (ttm)	3.94	Insider Own	12.38%	Shs Outstand	22.88M	Perf Week	6.30%
Market Cap	1.92B	Forward P/E	7.78	EPS next Y	10.86	Insider Trans	-4.50%	Shs Float	19.93M	Perf Month	3.35%
Enterprise Value	2.21B	PEG	0.48	EPS next Q	2.01	Inst Own	104.31%	Short Float	16.06%	Perf Quarter	13.97%
Income	83.93M	P/S	2.08	EPS this Y	19.22%	Inst Trans	11.14%	Short Ratio	9.23	Perf Half Y	4.67%
Sales	923.71M	P/B	3.44	EPS next Y	15.40%	ROA	6.24%	Short Interest	3.20M	Perf YTD	7.04%
Book/sh	24.57	P/C	5.89	EPS next 5Y	16.29%	ROE	17.27%	52W High	99.50 -15.08%	Perf Year	28.40%
Cash/sh	14.34	P/FCF	10.05	EPS past 3/5Y	- -	ROIC	7.32%	52W Low	62.60 34.97%	Perf 3Y	58.92%
Dividend Est.	-	EV/EBITDA	11.32	Sales past 3/5Y	40.81% 33.48%	Gross Margin	51.14%	Volatility	3.51% 3.14%	Perf 5Y	155.75%
Dividend TTM	-	EV/Sales	2.39	EPS Y/Y TTM	425.94%	Oper. Margin	11.46%	ATR (14)	2.62	Perf 10Y	55.50%
Dividend Ex-Date	-	Quick Ratio	2.52	Sales Y/Y TTM	37.03%	Profit Margin	9.09%	RSI (14)	61.02	Recom	1.17
Dividend Gr. 3/5Y	- -	Current Ratio	3.12	EPS Q/Q	86.11%	SMA20	4.89%	Beta	0.42	Target Price	114.17
Payout	0.00%	Debt/Eq	1.09	Sales Q/Q	20.46%	SMA50	4.85%	Rel Volume	2.25	Prev Close	83.28
Employees	970	LT Debt/Eq	1.06	Earnings	May 08 BMO	SMA200	2.14%	Avg Volume	346.85K	Price	84.50
IPO	May 12, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	57.84% 14.37%	Trades		Volume	779,997	Change	1.46%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)